In most clinical trials for cancer therapy, investigators test treatments in patients with advanced disease. But a recent cardiovascular secondary prevention study has given researchers a unique opportunity: to explore the effectiveness of giving a drug to patients before cancer emerges.
from Top Health News – ScienceDaily http://ift.tt/2xqNorA
from Tumblr http://ift.tt/2xGniQO
No comments:
Post a Comment